Rivastigmine Patch: Supply Issue

Supply issue Active

The supplier of Rivastigmine patch, Boucher and Muir, is experiencing supply issues with Rivastigmine Patch BNM 5.

Update 24 January 2024

The Rivastigmine Patch BNM 10 (9.5 mg per 24 hour) is back in stock with the supplier. Wholesalers may require pharmacists to use up the Novartis brand before supplying the BNM brand. 

The Novartis Exelon Patch 5 will continue to be supplied until about April 2024. 

We do not have a delisting date for the Novartis patches yet.

Affected product

The supplier of rivastigmine patches, Boucher and Muir, has advised that it is experiencing supply issues with the Rivastigmine Patch BNM 5. Supply is expected to be constrained until April 2024. The Rivastigmine Patch BNM 10 was resupplied in January 2024.

Chemical: Rivastigmine Patch BNM 5(external link)
Measure: 4.6 mg per 24 hour
Pharmacode: 2611570
Status: Out of stock

Chemical: Rivastigmine Patch BNM 10
Measure: 9.5 mg per 24 hour
Pharmacode: 2611589
Status: Resupplied January 2024

Rivastigmine patch Schedule listing(external link)

Alternative product

From 1 October 2023 an alternative product will be listed on the Pharmaceutical Schedule. Supplies arrived in September. They should be making their way through the supply chain. 

Chemical: Rivastigmine 
Brand: Novartis Exelon Patch 5
Measure: 4.6 mg per 24 hour
Pharmacode: 2273616

Chemical: Rivastigmine 
Brand: Novartis Exelon Patch 10
Measure: 9.5 mg per 24 hour
Pharmacode: 2273608

The Novartis Exelon brand is registered.

Expected resupply

Rivastigmine Patch BNM 5 is expected to be resupplied in April 2024.

Rivastigmine Patch BNM 10 (9.5 mg per 24 hour Pharmacode: 2611589) is resupplied.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.  

Sign up to our email list for regular emails about supply issues and more(external link)